ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

Bioness’s PoNS system is designed to improve gait impairment in stroke patients by stimulating the trigeminal and facial ...

For much of modern psychiatry, the brain has been treated indirectly with medications altering neurotransmitters—serotonin, dopamine, norepinephrine—under the assumption that downstream effects will ...

SAN CLEMENTE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will ...